Stay updated on Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial

Sign up to get notified when there's something new on the Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical trial record for nab-sirolimus combined with FOLFOX and bevacizumab in advanced or metastatic colorectal cancer is displayed, including study design, participant criteria, locations, outcome measures, record dates, and a study protocol document.
    Difference
    47%
    Check dated 2026-11-09T00:28:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T00:16:31.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-26T00:25:54.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T00:26:40.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T00:27:48.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a Home button and a revision tag, signaling access is blocked to the study page. It reflects an error state rather than substantive study content.
    Difference
    18%
    Check dated 2026-09-20T22:58:57.000Z thumbnail image

Stay in the know with updates to Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial page.